Product Information
TETRACAINE 0.5% EYE DROP is a generic product labeled by Bausch & Lomb Americas Inc., priced at $4.3298 per ML under NDC 82260092005. Its NADAC has been published 43 times since Dec 10, 2025.
FDA first approved this application on Mar 12, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/mL
Manufacturer
Bausch & Lomb Americas Inc.NDC
82260092005
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
TETRACAINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA210821FDA Approved
3/12/2019
TE Code
AB1
On Market Since
9/21/2022
Pharmacological Classes
Price Statistics
The NADAC for TETRACAINE 0.5% EYE DROP has been published 43 times since Dec 10, 2025, and over the history we have for it it has declined 8.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.3298 per ML |
|---|---|
| All-time high | $4.8624 (Mar 11, 2026) |
| All-time low | $3.9931 (Jun 17, 2026) |
| 52-week high | $4.8624 |
| 52-week low | $3.9931 |
| Median price | $4.1673 |
| Average price | $4.3780 |
| Largest weekly change | -10.1% (Mar 18, 2026) |
| Weeks tracked | 43 |
| Tracking since | Dec 10, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Bausch & Lomb Americas Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tetracaine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Ester Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TETRACAINE 0.5% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TETRACAINE 0.5% EYE DROP, manufactured by Bausch & Lomb Americas Inc., is $4.3298 per ML (NDC 82260092005), effective Sep 30, 2026.
How has the price of TETRACAINE 0.5% EYE DROP changed over time?
Over the history we have for it, the NADAC for TETRACAINE 0.5% EYE DROP has declined 8.9%. It has been tracked across 43 weekly CMS publications since Dec 10, 2025.
What are the highest and lowest recorded NADAC prices for TETRACAINE 0.5% EYE DROP?
Since Dec 10, 2025, the NADAC for TETRACAINE 0.5% EYE DROP has ranged from a low of $3.9931 (Jun 17, 2026) to a high of $4.8624 (Mar 11, 2026), with a median of $4.1673 per ML.
Are there cheaper alternatives to TETRACAINE 0.5% EYE DROP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TETRACAINE 0.5% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures TETRACAINE 0.5% EYE DROP?
TETRACAINE 0.5% EYE DROP (NDC 82260092005) is labeled by Bausch & Lomb Americas Inc., and CMS classifies it as a generic product.